GlassScriptPhysician profile
Shawn D Teague
NPI 1386687481
$195,012.35
in general payments reported to CMS, 2019-2025
6 companies · $5,796 in 2025
The $5,796 reported for 2025 was more than what 95% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $47K · 2020: $32K · 2021: $35K · 2022: $5,049 · 2023: $39K · 2024: $31K · 2025: $5,796.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $47K · Travel and Lodging: $15K · Consulting Fee: $12K · Food and Beverage: $1,437.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $47,200.00 |
| Travel and Lodging | $15,102.09 |
| Consulting Fee | $11,805.00 |
| Food and Beverage | $1,437.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $162,968.95 | 2019-2025 | Ofev |
| Boehringer Ingelheim Pharma Gmbh & Co.Kg | $24,750.00 | 2021 | |
| Genentech USA, INC. | $6,454.86 | 2020 | |
| Siemens Medical Solutions USA, INC. | $786.03 | 2023-2025 | Naeotom Alpha |
| Abiomed | $27.02 | 2024 | Impella |
| Ge Healthcare | $25.49 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shawn Teague listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.